| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |